10:00 AM EST - Microbix Biosystems Inc. : Reports results for its third quarter ended June 30, 2023. Q3 revenue was $5,530,152, an increase of 10% from Q3 2022 revenues of $5,011,025. Overall, Q3 sales led to an operating and net loss of $769,108 versus a Q3 2022 operating and net income of $638,502. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.32.
